https://doi.org/10.4081/monaldi.2013.26
Roflumilast: the fourth Mousquetaire in COPD pharmacological treatment
Submitted: August 18, 2015
Accepted: August 18, 2015
Published: August 19, 2015
Accepted: August 18, 2015
Abstract Views: 896
PDF: 585
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
How to Cite
Balbi, Bruno. 2015. “Roflumilast: The Fourth Mousquetaire in COPD Pharmacological Treatment”. Monaldi Archives for Chest Disease 79 (3-4). https://doi.org/10.4081/monaldi.2013.26.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Michele Vitacca, Piero Ceriana, Bruno Balbi , Claudio Bruschi, Maria Aliani, Mauro Maniscalco, Francesco Fanfulla, Aldo Diasparra, Luigino Rizzello, Daniela Sereni, Antonio Spanevello, The respiratory rehabilitation Maugeri network service reconfiguration after 1 year of COVID-19 , Monaldi Archives for Chest Disease: Vol. 91 No. 4 (2021)
- A.L. Kruis, N.H. Chavannes, Potential benefits of integrated COPD management in primary care , Monaldi Archives for Chest Disease: Vol. 73 No. 3 (2010): Pulmonary series
- Y. Lacasse, L. Beaudoin, L. Rousseau, F. Maltais, Randomized trial of paroxetine in end-stage COPD , Monaldi Archives for Chest Disease: Vol. 61 No. 3 (2004): Pulmonary series
- S. Baldi, G.D. Pinna, P. Crotti, S. Montemartini, E. Dacosto, F. Fanfulla, C. Fracchia, C. Bruschi, Nutritional status and airflow obstruction: two independent contributors to CO diffusing capacity impairment in COPD , Monaldi Archives for Chest Disease: Vol. 63 No. 1 (2005): Pulmonary series
- P. Santus, F. Casanova, M.L. Biondi, F. Blasi, F. Di Marco, S. Centanni, Stromelysin-1 polymorphism as a new potential risk factor in progression of chronic obstructive pulmonary disease , Monaldi Archives for Chest Disease: Vol. 71 No. 1 (2009): Pulmonary series
- M. Lusuardi, F. Blasi, C. Terzano, C. Cricelli, N. Crispino, L. Comarella, F. De Benedetto, C.M. Sanguinetti, L. Allegra, C.F. Donner, Standards of care and clinical predictors in patients hospitalised for a COPD exacerbation - The Italian SOS (Stratification Observational Study) , Monaldi Archives for Chest Disease: Vol. 71 No. 4 (2009): Pulmonary series
- Teona Avaliani, Yuliia Sereda, Hayk Davtyan, Nestani Tukvadze, Tamar Togonidze, Nana Kiria, Olga Denisiuk, Ogtay Gozalov, Sevim Ahmedov, Arax Hovhannesyan, Effectiveness and safety of fully oral modified shorter treatment regimen for multidrug-resistant tuberculosis in Georgia, 2019-2020 , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- B. Singh, S. Arora, V. Khanna, Association of severity of COPD with IgE and interleukin-1beta , Monaldi Archives for Chest Disease: Vol. 73 No. 2 (2010): Pulmonary series
- Soundariya Krishnamurthy, Yuvarajan Sivagnaname, Gokul Chandu Gumallapu, Identification of subclinical cognitive impairment in chronic obstructive pulmonary disease using auditory P300 event related potential , Monaldi Archives for Chest Disease: Vol. 89 No. 2 (2019)
- Valeriu Plesca, Ana Ciobanu, Yuliia Sereda, Andrei Dadu, Do catastrophic costs impact treatment outcomes in people with rifampicin-resistant tuberculosis in the Republic of Moldova? , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
You may also start an advanced similarity search for this article.
